Impairment of drug metabolism in patients with liver cancer.
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000983:Antipyrine / Q000378:metabolism; D001219:Aspartate Aminotransferases / Q000097:blood; D001579:Benzopyrene Hydroxylase / Q000378:metabolism; D001663:Bilirubin / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000378:metabolism*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D005260:Female; D006801:Humans; D008099:Liver / Q000378:metabolism; D008113:Liver Neoplasms / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010088:Oxidoreductases / Q000378:metabolism; D012709:Serum Albumin / Q000378:metabolism
D012709:Serum Albumin; D003577:Cytochrome P-450 Enzyme System; D010088:Oxidoreductases; D001579:Benzopyrene Hydroxylase; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001663:Bilirubin; D000983:Antipyrine